EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSMOCG00000007921
Gene Symbol: RXRA
3 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSMOCG00000000374
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSMOCG00000021255
Gene Symbol: RPL11
3 Cross references
158 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSMOCG00000002774
Gene Symbol: RPL13A
2 Cross references
305 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSMOCG00000004837
Gene Symbol: RPL14
2 Cross references
251 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMOCG00000016013
Gene Symbol: RPL18
2 Cross references
238 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSMOCG00000021467
Gene Symbol: RPL19
3 Cross references
241 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMOCG00000013028
Gene Symbol: RPL22
3 Cross references
92 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSMOCG00000018924
Gene Symbol: RPL24
3 Cross references
301 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSMOCG00000020834
Gene Symbol: RPL26
2 Cross references
137 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSMOCG00000006245
Gene Symbol: RPL28
3 Cross references
198 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSMOCG00000020926
Gene Symbol: RPL29
2 Cross references
472 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).